Contrave: New Obesity Drug Nears Market
December 23, 2010
An FDA advisory panel recommended the agency approve a new weight-loss drug called Contrave. This would be the first prescription obesity drug approved in a decade.
Topics:
Hospitality Recreation, Health Medical Pharma, Social Issues, Anti-obesity medication, Obesity, Bariatrics, Rimonabant, Eli Lilly controversies, Food and Drug Administration
